Quantification of DNA Methylation for Diagnosis and Monitoring of Hepatocellular Carcinoma
HBMV is a sensitive and biologically grounded biomarker for HCC diagnosis, prognosis, and real-time disease monitoring. These findings support further prospective evaluation of HBMV as a noninvasive tool for clinical surveillance and assessment of treatment response.
Authors
- Steven J. Hughes (ORCID: https://orcid.org/0000-0002-5688-6942)
- Rohan Ganguli (ORCID: https://orcid.org/0000-0003-2007-398X)
- ALI ZARRINPAR
- Salar Javanshir (ORCID: https://orcid.org/0000-0002-6481-0737)
- Anastasia Chambers
- Ilyas Sahin
- Pavan Iyengar
- Sergio Duarte
- Isabella Angeli-Pahim
- Iulia Maria Smarandache
Institutions
- University of Florida Health (US)
- Massachusetts General Hospital (US)
- Center for Cancer Research (US)
Publication Details
- Journal
- Journal of the American College of Surgeons
- Published
- 2026-01-23
- DOI
- https://doi.org/10.1097/xcs.0000000000001792
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.00